Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis

Clinical trial NCT02376790 · COMPLETED

Trial details

NCT number: NCT02376790
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2015-03-03
Primary completion: 2018-01-09
Enrollment: 851

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.